Also trades as: AUP.TO (TSX) · $vol 4M
AUPH NASDAQ
Aurinia Pharmaceuticals Inc.
1W: -2.5%
1M: -5.9%
3M: +7.3%
YTD: +0.7%
1Y: +86.1%
3Y: +51.3%
5Y: +29.6%
$15.22
-0.23 (-1.49%)
Weekly Expected Move ±6.0%
$13
$14
$15
$16
$17
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$298M
Revenue
+20.6% YoY
$298M
Net Income
+648.4% YoY
$166M
Free Cash Flow
+158.7% YoY
91.6%
Gross Margin
53.3%
Op. Margin
44.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE62.2%
ROA45.8%
ROIC107.5%
Valuation
P/E6.8
P/B3.6
EV/EBITDA10.6
Leverage
Debt/Equity0.13
Current Ratio5.25
Interest Cov.16.5x
Quality Scores
Piotroski F8/9
Altman Z7.64
Beneish M8.45